Euractiv Est. 1min 04-12-2020 (updated: 16-12-2020 ) Nanomedicine uses state-of-the-art nanotechnology like nanoparticles, nanorobots or nanoelectronic biosensors for diagnosing or treating cancer, cardiovascular, and neurodegenerative diseases. [Shutterstock/anyaivanova] Euractiv is part of the Trust Project >>> Print Email Facebook X LinkedIn WhatsApp Telegram Nanomedicines are emerging as an innovative technology in the scientific field, as they help address unmet medical needs and offer alternatives for many therapeutic areas. Nanomedicine uses state-of-the-art nanotechnology like nanoparticles, nanorobots or nanoelectronic biosensors for diagnosing or treating cancer, cardiovascular, and neurodegenerative diseases. However, a number of issues related to the regulatory framework raise more questions than answers while critics suggest that without an EU-centralised approach, the potential of nanomedicines will remain untapped. Download PDF Nanotechnology: Part of COVID-19 vaccines but potential still hindered in Europe News | Health 04-12-2020 Est. 4minNanotechnology has contributed to the production of vaccines against the COVID-19 virus. However, in Europe, a de-centralised and vague regulatory framework prevents nanomedicines from harnessing their full potential to save lives. MEP: Parliament will pressure Commission to focus on nanomedicines News | Health 08-12-2020 Est. 3minThe European Parliament will put pressure on the Commission and the member states to provide the necessary regulatory framework for nanomedicines in order to better make use of their potential for patients, EU lawmaker Pietro Fiocchi told EURACTIV in an interview. Pharmaceutical Strategy must do more to support nanomedicines Opinion | Promoted content | Health 16-12-2020 Est. 5minThe EU’s Pharmaceutical Strategy must do more to support nanomedicines and protect patient safety. Here’s why. Mike Isles is the Executive Director of the European Alliance for Access to Safe Medicines (EAASM). If Europe is to make its world-leading pharmaceutical sector fit …
